Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

African-Americans' attitudes about lung cancer may hinder prevention

22.02.2010
A new survey has found that African-Americans are more likely than whites to hold mistaken and fatalistic beliefs about lung cancer, as well as being more reluctant to consult a doctor about possible symptoms of the disease, according to researchers from Dana-Farber Cancer Institute and their collaborators.

These attitudes among blacks may help explain the puzzling racial disparities in lung cancer treatment outcomes that have been documented over the past 25 years, and highlight the need for clearer, more direct public health messages directed at African-Americans, say the scientists.

Christopher Lathan, MD, MPH, an oncologist in the Division of Population Sciences at Dana-Farber, is the first author of the report in the journal Cancer. Senior author is Gary Bennett, PhD, of Duke University's Global Health Institute.

Both whites and blacks in the survey "grossly underestimated" the bleak outlook associated with a diagnosis of lung cancer – only 15 percent of patients survive for five years. Lung cancer is the most lethal cancer in the United States, and among people diagnosed with the disease, African-American men have the highest incidence and mortality. Blacks tend to be diagnosed later than whites, when the disease is more advanced.

Federal data quoted in the paper say that the 2001-2005 incidence rate of lung cancer for white men was 79.3 per 100,000 vs. 107.6 per 100,000 for African-American men, and the mortality rate for white men with lung cancer is 71.3 per 100,000 vs. 93.1 per 100,000 for African-American men. This survival gap was first detected in the early 1980s, and continues today.

Previous studies have suggested that the disparity may be due in part to differences in access to care, rates of surgery, and patient preferences, Lathan says. The current study was undertaken to find out "if African-Americans think about lung cancer in a different way," explains Lathan.

Using a random-digit phone dialing method, the investigators queried patients who had been participants in the National Cancer Institute's 2005 Health Information National Trends Survey (HINTS).

Both black and white respondents greatly overestimated the percentage of lung cancer patients who survive 5 years or longer – many said 50 percent when the true number is 15 percent.

There were three survey questions on which blacks and whites diverged significantly. African-Americans were more likely than whites (53 percent vs. 37 percent) to say they were confused by too many recommendations on how to prevent lung cancer. "This is shocking," says Lathan. "There is only one recommendation to decrease the chance of getting lung cancer. Stop smoking and avoid tobacco smoke."

When asked whether the disease is caused by lifestyle and behavior, 73 percent of blacks agreed, compared to 85 percent of whites.

Among blacks, 22 percent said they would be reluctant to be checked for lung cancer symptoms out of fear of receiving bad news. Only 9 percent of whites agreed with this statement. In addition, 51 percent of African-Americans believed that they would have symptoms before a diagnosis of lung cancer, versus 32 percent of whites.

The researchers concluded, "African Americans are more likely to hold beliefs about lung cancer that could interfere with prevention and treatment."

"We really need to target out lung cancer education to communities of color," says Lathan. "And we need to deliver really clear messages: Stop smoking if you want to prevent lung cancer. You should go to see your doctor. And we should let people known that lung cancer is deadly – more deadly than breast, prostate and colon cancer combined."

Other authors of the report are Cassandra Okechukwu, DSc, of the University of California at San Francisco and Bettina F. Drake, PhD, MPH, formerly of the Center for Community-Based Research at Dana-Farber and now at the Siteman Cancer Center at Washington University in St. Louis.

The research was funded by the National Cancer Institute.

Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding.

Robbin Ray | EurekAlert!
Further information:
http://www.dfci.harvard.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>